Clinical endpoints measured in terms of duration, such as intensive care unit (ICU) length of stay (LOS), are widely used in randomized clinical trials (RCTs) and observational research. In analyses of patient-level data from a recent RCT, in which ICU LOS was the primary endpoint, and in administrative data, we showed that additional ICU time is often accrued by patients after they are deemed ready for discharge. This "immutable" time (which cannot plausibly be altered by interventions under study) varies by day, week, and year, adding on average one-third of a day to total LOS. We then used statistical simulations, informed by the administrative data and RCT, to assess the impact of immutable time on the measurement and statistical comparison of patients' ICU LOS. These simulations demonstrated that immutable time combines with clinically necessary ICU time (neither of which is likely to be normally distributed) to produce overall LOS distributions that might either mask true treatment effects or suggest false treatment effects relative to analyses of time to discharge readiness. The extent and direction of bias were complex functions of the statistical method used, mortality rates and distributions, and the magnitude of immutable time relative to intervention-associated reductions in LOS.
Patient length of stay (LOS) in the intensive care unit (ICU) tracks closely with resource utilization, cost, and capacity (1) . ICU LOS is also the most common outcome measure in ICUbased randomized clinical trials (RCTs) (2) . Due to the ease of measurement using electronic health records and statistical efficiency as a continuous outcome (3), ICU LOS is potentially a valuable metric of effectiveness that can be compared across trials.
Unfortunately, several problems exist with the measurement and analysis of ICU LOS (4) . For example, when evaluating the effect of a clinical intervention on LOS, one wishes to determine the intervention's impact on the time required for patients to become clinically ready for ICU discharge. Yet ICU-based RCTs often report total LOS, which includes time from ICU admission (potentially prior to an ICU-based intervention) until actual ICU discharge. Because most ICU discharges entail patients transitioning to a step-down unit or general ward, factors such as bed availability and clinical rounding schedules could impact actual discharge time, independent of patients' illnesses or the interventions they receive (5) .
Motivated by a dilemma we encountered in analyzing the Study to Understand Nighttime Staffing Effectiveness in a Tertiary Care ICU (SUNSET-ICU) trial (6), we examined the epidemiology and implications of such "immutable time," defined as extra LOS time that cannot plausibly be affected by interventions such as pharmacotherapies or ventilation strategies ( Figure 1) . We first performed a systematic review of ICU-based RCTs to identify prior studies that have defined ICU LOS using discharge readiness as the end time rather than actual discharge. Next, we used statistical simulations, informed by our own RCT (6) and administrative data, to quantify the extent to which immutable time might bias estimates of treatment effects across a range of possible trial scenarios.
METHODS

Empirical framework
The statistical model,
i , represents a common analysis conducted in RCTs to quantify the effect of an intervention; here Y is ICU LOS, X is a binary indicator for treatment arm generally measured without error, and ϵ indicates stochastic error. A parameter, β, is used to quantify the difference between the intervention and control LOS (for example, in the linear model, ( ) = α + β f X X i i ). However, in lieu of LOS based on a patient's readiness for discharge, Y i , the value of ICU LOS with immutable time,
, where ν i is the immutable time unaffected by treatment arm. We assume ν i is independent of X i and ϵ i . Under this framework, the additional bias term, ν i , results in the following:
i , where θ i is an error term that is biased by measurement error. In some trial designs, early immutable time could also occur between the time of ICU admission and exposure to an intervention ( Figure 1 ) and would effectively increase the mean and variability of the immutable time distribution.
While immutable time is essentially random and likely independent of treatment arm assignment, LOS and immutable time are generally not normally distributed (Figure 2 and Web Figures 1-3 , available at https://academic.oup.com/aje). Further, ICU LOS consists of a heterogeneous mix of subjects who die and those who survive. Consequently, ICU LOS might represent 2 very distinct clinical outcomes: For some subjects, ICU LOS represents time to death and for others, time to discharge. Because immutable time incurred due to ward bed availability would not affect patients who die in the ICU, immutable time typically affects survivors more than decedents. This could result in ν following a more complex mixture of non-normal distributions in studies with both early and late immutable time.
Data analysis
Literature review. To identify the use of time to discharge readiness to compare interventions in practice, we examined ICU-based RCTs published from January 2007 to June 2015 in 16 impactful journals that assessed ICU LOS as a primary or secondary endpoint. We have previously published details regarding the development of this database (2) .
Secondary data analysis and motivating examples. We examined daily, weekly, and yearly variation in discharge We designed a simulation study using empirical data from the SUNSET-ICU trial with additional settings informed by the administrative data described above. The goal of the simulation study was to assess the effect of immutable time on the interpretation of analytic results. Two data-generation strategies were used: 1) a principal stratification framework where the fraction of deaths and time-to-death distributions were equivalent in the study arms, and 2) a competing risks framework in which a treatment-associated hastening of time to discharge resulted in a lower ICU mortality rate among those treated (without modifying the underlying equivalence of the time to death in the 2 arms). Both approaches are detailed in Web Appendix 1.
We assumed that immutable time might affect surviving patients' time to discharge readiness but not time to death among those who die in the ICU. Thus, to create the simulated data, first we generated an error-free ICU LOS, representing time to discharge readiness for survivors and time to death for decedents, from a Weibull distribution. Based on the ICU LOS distribution in the SUNSET-ICU trial, we used a distribution with a median of 2.5 days (interquartile range, 1.2-4.5 days). We imposed 1 of 3 hypothetical treatment effects (i.e., 0-, 0.5-, and 1-day reductions) at the median time to discharge readiness for the treatment arm (Web Appendix 1). Next, 3 immutable time distributions with medians of approximately 8 hours, 16 hours, and 28 hours (settings 1, 2, and 3, respectively) were generated from a gamma distribution and randomly added onto the time to discharge readiness of survivors who were discharged (Web Figure 4) . Setting 1 was based on late (i.e., discharge) immutable time observed in the SUNSET-ICU trial. Setting 2 was based on the longer distributions of late immutable time from our administrative data. Setting 3 sought to assess very long but still plausible immutable time. This might arise, for example, if the late immutable time in Setting 2 was observed concurrently with a median of 12 hours of early immutable time between ICU admission and exposure to an intervention. Hence, for each simulated trial, 4 LOS values were generated: an error-free LOS and 3 LOS distributions with immutable time added onto survivors' LOS.
Within each simulated trial replicate, we examined the impact of immutable time using 4 statistical approaches for comparing LOS that are commonly encountered in the literature (with example RCTs for each):
• Nonparametric comparison (i.e., a Wilcoxon rank-sum test) (7) • Parametric comparison (i.e., an ordinary least squares linear regression or t test) (8) • Cox proportional hazards model of the time to ICU discharge (with death as a censoring event) (6) • ICU-free days, where patients who die during the study period or remain in the ICU after the end of the follow-up period (e.g., 30 days) are coded as having zero ICU-free days, and ICU-free days for others are calculated as: followup period -ICU LOS (9) . The distributions of ICU-free days are then compared using a nonparametric comparison (10).
For each simulation setting, we varied the total sample size (number of patients: 200, 400, 600, 800, 1,000, and 1,500) to reflect the range of sample sizes observed in the majority of ICU-based trials (2) . All settings assumed an equal number of patients in each of the 2 study arms (1:1 randomization) and used 1,000 Monte Carlo replicates with administrative censoring at 30 days.
To quantify the potential effect of immutable time on the interpretation of analytic results, we summarized the percentage of times a 2-sided statistical test in the 3 immutable time settings differed from the error-free LOS at the α = 0.05 level. Replicates were classified as false positive if the intervention generated an effect on LOS at P < 0.05 in the presence of immutable time but the same test yielded P ≥ 0.05 in the absence of immutable time. Replicates were classified as false negative in the reverse situation.
RESULTS
Literature review
Trial investigators explicitly reported a statistical comparison of time to discharge readiness in 5 of 150 trials (3%) that reported the results of a statistical test on an ICU LOS outcome (Web Table 1 ). Two trials used an end time that was defined by clinical criteria, and 2 did not specify their clinical criteria. In the fifth, the SUNSET-ICU trial, time to discharge readiness ended at the time when an electronic order for transfer from the ICU was placed.
Secondary data analysis
Early immutable time was not applicable to 867 (54%) of the 1,598 SUNSET-ICU trial participants admitted during the nighttime exposure period (7 PM to 6:59 AM). Among the 731 (46%) patients admitted outside this time, the median early immutable time was 4.0 hours (interquartile range, 2.0-7.3 hours) (Web Figure 1) .
Among the 1,149 MICU discharges to another hospital unit or ward among SUNSET-ICU trial participants, we observed a median time to discharge readiness of 40.1 hours compared to 46.8 hours of time from admission to actual discharge (Figure 2) . The median difference between time to discharge readiness and time to actual discharge (i.e., immutable time) was 5.1 hours (interquartile range, 2.7-8.9 hours; 90th percentile = 14.2 and 95th percentile = 21.7) (Web Table 2 ).
From the administrative data of all MICU patients at our center in calendar years 2010-2012, we identified 3,851 discharges from the MICU. The median immutable time was 7.0 hours (interquartile range, 4.3-11.1 hours; 90th percentile = 21.6 and 95th percentile = 29.5), and there was considerable weekly, monthly, and yearly variation (Web Figures 2  and 3 ). More than half of all discharge requests were placed between 8 AM and 9 AM, during which time the MICU's morning bed-management rounds occur (Figure 3 ).
Simulation study
When data were simulated with no treatment effect, with a few exceptions in the largest immutable time setting (setting 3), less than 2%-3% of replicates had an inferential mismatch due to immutable time (Web Figure 5) . In the presence of a treatment effect, the rate of inferential mismatches varied considerably depending on the statistical approach used. Generally, inferential differences between the error-free and immutable time LOS tended to decrease as 1) sample size increased, 2) mortality rates decreased, and/or 3) the magnitude of the treatment effect increased relative to the median immutable time (Figure 4 and Web Figures 6-11 ). For example, in settings that simulated a half-day median reduction in LOS and a 20% control-arm mortality rate, false inference rates as high as 5% in setting 1 and 15% in setting 3 were observed ( Figure 4 and Web Figure 7 ). In the settings with a full-day LOS treatment effect at the median, false inferences tended to be isolated to the smaller sample sizes of 200-600 (Web Figures 9-11 ). Larger immutable times (settings 2 and 3) consistently increased the frequency of inferential differences across all scenarios.
Inferential differences between the 2 data-generation approaches became apparent as mortality increased. The Wilcoxon rank-sum test and linear regression model tended to report mostly false negatives and have higher overall false inferential rates under the competing risks framework. The ICU-free-day metric, which values LOS as zero for decedents, reduced inferential errors as the mortality rate increased under the competing risks framework but less so under the principal stratification framework. The Cox time-to-event model exhibited higher, and mostly false-positive, rates as overall mortality increased from 10% to 40% under principal stratification data generation. These rates were much lower and isolated to small sample sizes in the competing risks framework. In many cases, the false-positive and false-negative interpretations result from small changes in the observed P values relative to those that would have been obtained in the absence of immutable time.
DISCUSSION
The increasing uptake of "duration endpoints," such as LOS in randomized trials, requires scrutiny of the various definitions, analytic approaches, and inherent biases of these metrics. The present study provides several important findings in this regard. First, fewer than 5% of published ICU-based RCTs in the modern era have reported defining LOS as the time to discharge readiness. Second, our reanalysis of data from the SUNSET-ICU trial revealed that participants remained in the ICU for substantial periods of time after their clinical improvement was confirmed with a discharge order. This immutable time, unlikely to be related to a treatment effect, was even larger and more varied in subsequent examination of our center's administrative data over a 3-year period.
Third, through a series of simulations, we found that immutable time could lead to different conclusions about how interventions might affect when patients are ready to leave the ICU. Furthermore, the extents and directions of these biases varied based on the statistical approach used, the overall and arm-specific mortality, and the sample size. These difficultto-predict effects arise because ICU LOS is not a homogeneous distribution but rather comprises time-to-death and time-todischarge subdistributions. An intervention can impose complex changes on these various subdistributions, and immutable time adds an additional layer of inferential complexity. While immutable time predominantly masked statistically significant reductions in the simulated time to discharge readiness (false negatives), false positives were also observed in the setting of small true effects of the intervention on LOS. As the size of the treatment effect increased, the more favorable signal-tonoise ratio mitigated the impact of immutable time. Therefore, the potential consequences of immutable time appear to be most relevant in studies in which clinically relevant treatment effects are numerically small, as is commonly true in ICU-based RCTs (2, 11, 12) . Figure 3 . Cumulative radar frequency graph of the time of day that a discharge was requested (gray) and occurred (black) using a 24-hour clock, where 0 is midnight and 23 is 11 PM, summarizing 3,851 discharges from the medical intensive care unit at the Hospital of the University of Pennsylvania between 2010 and 2012 (n = 156 weeks). The numbers inside the circles indicate 5%, 15%, and 54% of the total, with 54% (n = 2,076) of the discharges requested between 8 AM and 9 AM, when morning bed-management rounds occurred. The second spike of the hour of bed-request curve, at roughly 5 PM, coincided with the typical timing of evening bed-management rounds.
Considering these observations, we propose the following recommendations to researchers who plan to analyze ICU LOS (or any susceptible duration measure). First, investigators should clearly report the start and end times used to define LOS, and ideally end their measurement of LOS when patients are clinically ready for discharge. Second, we recommend that neither a t test nor a Wilcoxon rank-sum test be used to compare ICU LOS. In addition to being highly susceptible to immutable time bias, the distributional assumptions of parametric models are unlikely to be met (Figure 2) , and neither of these approaches accounts for informative censoring from mortality (4) . Both the ICU-free-day derivation of ICU LOS and the use of a time-to-event model (i.e., time to discharge using a Cox model) address this informative censoring issue, although in different ways. A Cox model estimates the time to discharge by treating death as a censoring event, which assumes that censoring is random and nondifferential between study arms. This assumption might or might not hold true in practice and is difficult to verify. By contrast, the ICU-free-day approach is limited in that it makes a judgment about the value of death (i.e., equal to never leaving the ICU). More recent innovations that contrast ICU LOS assuming different ICU LOS values for those who die (e.g., death is equal to the median or 75th percentile of ICU LOS (4)) could offer the dual benefits of managing the time-to-death component of LOS with less susceptibility to bias from immutable time.
In interpreting this work, the implications of several modeling assumptions must be considered. First, although useful for illustration, an important limitation of our simulation study is the assumption that immutable time would be nondifferential across arms. This assumption might not be true in practice. For instance, in our analysis of 3 years of administrative data from one MICU, we found that the duration of immutable time varied by week and year (Web Figures 2 and 3) , suggesting that immutable time might be differentially added to patients treated in the same ICU over time. A second assumption that might not hold in clinical practice is that the effects of immutable time would accrue consistently across patient subgroups. In fact, special 11 and Web Appendix 1. Using a 2-sided statistical test for differences between study arms, a false positive was operationally defined as finding a P value of <0.05 with immutable time added when the error-free LOS distribution had a P value ≥0.05. A false negative was operationally defined as finding a P value of ≥0.05 with immutable time added when the error-free LOS distribution had a P value <0.05.
patient populations might experience levels of immutable time that exceed the average for a given ICU (e.g., patients requiring contact precautions, telemetry, or higher-level nursing observation could take longer to discharge to appropriate ward beds). While these sources of variation would likely become evenly distributed between intervention arms over a sufficiently long recruitment period, particularly if randomization was done within center, these variations could conceivably lead to differential effects of immutable time across arms that could additionally distort treatment effect estimates (13, 14) . Third, we did not model early immutable time directly, as it might not apply in some trials and would be nondifferential in many of the trials in which it does apply. For example, the times of ICU admission, randomization, and intervention administration would be identical in a trial that randomly assigned different ventilation strategies to patients who were already mechanically ventilated at the time of ICU admission. By contrast, in our SUNSET-ICU trial, patients who were admitted during the day accrued early immutable time whereas those who were admitted to the ICU at night did not. Thus, while discharge immutable time will almost always exist to some extent among ICU survivors, the existence and size of early immutable time will vary based on study design, type of intervention, and patient eligibility criteria. The results of simulation setting 3 might help illustrate the combined impact of early and late immutable time. Although this simulation applied early immutable time only to survivors, whereas in reality it would also accrue for decedents, it led to inferential distortions even in the case with only 10% mortality.
Fourth, the ready-to-go time at our center was commonly observed during predictable times of day, immediately following morning and evening bed-management rounds (Figure 3) . The patterns observed within our US tertiary care center might not apply to different health-care systems or countries. While many ICUs employ similar strategies for reviewing admission and discharge priorities at discrete times of the day, these patterns could limit the applicability of our simulation to other units. Specifically, although all patients declared ready for discharge at these bed-management rounds were truly eligible for discharge, having been granted that status by their physicians, some of these patients were likely ready to go hours beforehand. Trials conducted in ICUs that more frequently assess patients for discharge readiness could experience either longer or shorter immutable time distributions (with heightened or reduced implications for statistical precision, respectively). Such ICUs could experience longer measured immutable time if ward discharge times are relatively constrained, in which case the longer gaps between the more accurately measured discharge readiness times and actual discharge times would exacerbate immutable time. By contrast, if more frequent assessment enabled more efficient discharge practices, this would limit the generation of immutable time.
Fifth, our simulations were not exhaustive. For example, alternative data-generation assumptions, such as longer median LOS, larger treatment effect sizes, and nonzero impacts on time to death, could influence LOS interpretation. In addition, our estimate of the proportion of ICU trials that have evaluated time to discharge readiness might have been affected by variations in the precision and detail of reporting by authors as well as by different reporting standards among journals. Further, although our literature search was conducted by a medical librarian, it is conceivable that our search strategy did not identify all eligible trials. Finally, in emphasizing that it is critical to evaluate time to discharge readiness so as to obtain less-biased estimates of interventions' effects on ICU LOS, we also recognize that some stakeholders, such as health-system administrators, might be more interested in seeing reductions in total ICU LOS.
In summary, LOS is an attractive endpoint for use in a wide range of health-care outcomes research because it is readily quantifiable and is important to patients, families, health systems, and payers. Indeed, it is the most widely used endpoint in ICU-based RCTs (2). While our study focused on LOS measurement error in the ICU, the issues we raise concerning immutable time are unlikely to be limited to ICU settings. Therefore, our results have potentially broad significance and applicability for randomized trial conduct, analysis, and reporting. Specifically, when using duration endpoints such as LOS, failing to consider or report definitions of the outcomes that are most plausibly related to interventions could result in inconsistency across trials, reduced power, and, potentially, bias.
